Insights
Product updates from Medicup, plus healthcare technology news curated from trusted outlets — CDC, FDA, and leading health-tech publications.
Artificial intelligence promises to make healthcare more efficient, but new guidance urges financial leaders to look past the sales pitch. Here's why smart AI adoption in the back office matters for your care.
New AI software is helping hospitals track controlled substances and prevent staff abuse, but the technology is only as good as the human oversight that supports it.
Two new companies, Sondermind and Limbic, have joined a key FDA pilot program aimed at evaluating digital health devices for treating anxiety and depression, signaling a major step forward for regulated digital therapeutics.
The FDA is taking its first steps toward regulating generative AI in medicine, seeking public feedback on the technology's risks and rewards. This move could shape the future of digital health tools for patients and providers.
Federal regulators are preparing to issue long-awaited guidance on generative AI in medicine. This is a critical step toward ensuring the AI tools used by patients and doctors are both safe and effective.
Amid a healthcare workforce crisis, a new paper from Cleveland Clinic shows that using AI-powered ambient scribes is paying off in clinician satisfaction and retention, validating a core principle of digital-first care.
As AI becomes a key tool in crisis response, new questions arise about power, governance, and accountability. A commentary in The Lancet Digital Health urges the global health community to build frameworks that ensure this technology serves humanity equitably and safely.
Humanitarian aid is facing critical shortfalls. New research highlights how AI could optimize resource distribution, but only if we navigate the serious ethical challenges first.
Imagine your doctor asking a chatbot, "What are this patient's latest lab results?" and getting an instant, accurate summary. This isn't science fiction; it's happening now.
In the fight against cancer, a critical question is being raised: could patients be receiving too much medication? Exploring the push for optimized, patient-specific dosing over the traditional 'maximum tolerated dose' approach.
The U.S. Food and Drug Administration has officially begun exploring how to regulate generative AI, a move that could build trust and ensure safety for new digital health tools.
Electronic health record (EHR) giant Epic is facing a federal antitrust probe. At the same time, it's rolling out a new wave of AI tools. Here's why this matters for the future of digital health.
